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Indirect evidence suggests that induced sputum derives from the
surfaces of the bronchial airways. To confirm this experimentally,
we employed a radiolabeled aerosol bolus delivery technique that
preferentially deposits aerosol in the central airways in humans.
We hypothesized that there would be significantly more radioac-
tivity recovered in an induced sputum sample, and greater airways
clearance of radiolabeled particles, immediately after a central
versus peripheral airways deposition. Ten healthy volunteers un-




Tc sulfur colloid par-
ticles) to the central and peripheral airways on separate occasions
followed immediately by induced sputum or no sputum (control),
while seated in front of a gamma camera. Radioactivity was mea-
sured in the selected sputum sample, processed cell pellet, and su-
pernatant fraction. Significantly more radioactivity was present in
all portions of the sputum sample after central versus peripheral













 0.001). Clearance from the whole
lung was significantly greater 40 min after central versus periph-













Compared with control, induced sputum greatly enhanced clear-




















0.8%). These results provide direct evidence that induced sputum
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Induced sputum by inhalation of hypertonic saline has been
used as a less invasive technique to examine airways inflam-
mation in healthy (1), allergic (2), and asthmatic individuals
(3, 4). Indirect evidence supports the assumption that induced
sputum selectively samples the surfaces of the bronchial air-
ways, while obtaining little or no secretions from the periph-
eral airways. Studies that have compared induced sputum
samples with bronchoalveolar lavage (BAL) in healthy sub-
jects at rest demonstrate that sputum samples contain a signif-
icantly greater percentage of neutrophils, an observation con-
sidered to reflect airways phenomena, whereas samples collected
from airways regions such as proximal bronchial secretions, tra-
cheal secretions, and bronchial wash (BW) have similar leuko-
cyte profiles to induced sputum (1, 5–8). We illustrated these
observations pictorially using quantitative flow cytometry in a
recent study (1). In that study, we also showed that macro-
phages and neutrophils recovered from induced sputum have
modified surface phenotypes and functional capacity com-
pared with the same cells from BAL (1), suggesting that these
cells derive from different lung compartments.
Moreover, several studies have shown that induced sputum
contains a higher concentration of fluid-phase components, such
as eosinophil cationic protein (ECP), mucinlike glycoprotein,
and albumin compared with BAL (6–9). These soluble com-
ponents are thought to be present largely in airway secretions
compared with alveolar spaces. Finally, cough is a critical
component in the sputum induction process. Clinical studies
examining airway clearance and deposition show that mucus
clearance by cough is highly effective predominantly in the
most proximal conducting (central) airways (10). All these
studies indirectly suggest that induced sputum selectively sam-
ples the central airways, but there is no direct evidence to sup-
port this. Thus, the goal of this study was to directly test this
hypothesis using quantifiable end points.
To achieve this aim, we used a novel aerosol generation
and delivery system to examine airway deposition and clear-
ance in human volunteers (11–14). This system has recently
been used to better characterize particle clearance kinetics from
the conducting airways by delivering small-volume (40-ml)
aerosol boluses to shallow volumetric lung depths (i.e., less than
150 ml). We have further refined this technique to deliver jet-




Tc) sulfur colloid (SC)
particles within large droplets in order to target their deposition
in the conducting airways, hereafter referred to as central air-
ways. Clearance kinetics of these centrally deposited particles
can also be compared with clearance from distal alveolar air-
spaces, hereafter referred to as peripheral airways, after large
tidal volume inhalation of fine droplets containing the radiola-
beled sulfur colloid particles. Using these novel aerosol deliv-
ery techniques, we hypothesized that if induced sputum de-
rives primarily from the central airways, this will be reflected
as significantly greater radioactivity recovered in the sputum
sample immediately after a central versus peripheral airway
deposition. Furthermore, if induced sputum is indeed an air-
ways phenomenon, clearance of radiolabeled particles from
the central airways should be markedly demonstrated imme-
diately after a central airways deposition. Likewise, little or no







Ten healthy, nonsmoking volunteers 18 to 40 yr of age (4 male, 6 fe-
male) were recruited to participate in the study. All subjects received
a medical examination on a separate screening day before beginning
the study, and informed written consent was obtained. Female sub-
jects provided a urine sample for pregnancy testing. A positive preg-
nancy test resulted in exclusion from the study. All subjects had no
history of lung disease (asthma, fibrosis, chronic obstructive pulmo-
nary disease) and had been free of upper or lower respiratory tract in-
fections for 4 to 6 wk before beginning the study. All subjects had a




) of greater than 80%
of predicted values for a population of similar height, weight, sex, age,
and race. Ethics approval for this study was obtained from the Com-
mittee on the Protection of the Rights of Human Subjects, School of
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Each subject received four radiolabeled aerosol depositions (two pe-
ripheral and two central) on four separate occasions. Each radiola-
beled particle exposure, whether central or peripheral, was approxi-




Ci of the radioisotope technetium-99m
(bound to SC) deposited in the lungs. Sputum induction was per-
formed immediately after one central and one peripheral deposition.
On each occasion, mucociliary clearance was measured over a 2-h pe-
riod and at 24-h by gamma camera imaging (Elscint large-field-of-view,
SP-4; Israel). A single-breath nitrogen washout test and a xenon-133
equilibrium scan (rebreathing 1 mCi/L) were performed on the first
visit before an aerosol deposition to determine anatomic dead space
(ADS) and lung volume imaging to normalize regional deposition, re-
spectively (12). Single-breath nitrogen washout was measured from
500 ml above FRC according to the technique of Fowler (15). Subjects








500 ml and exhaled again to residual volume (RV). A special Teflon
mouthpiece designed to reduce the volume of the oral cavity was used
for each individual. This same mouthpiece was used for the radiola-
beled bolus inhalations described subsequently. The exhaled volumes
associated with the ADS (exhaled volume through the midpoint of
phase 2 of the nitrogen washout curve, as determined by the equal
area technique [15]) were the average of three nitrogen washout
curves for each subject. Next, subjects received a randomly assigned
peripheral or central (bolus) aerosol deposition with or without spu-
tum induction. After each aerosol deposition, subjects rinsed their
mouths with water, and then sat with their back to the gamma camera
for two initial 2-min scans. Immediately after these scans, subjects
randomized to receive induced sputum underwent a modified induced
sputum procedure while seated in front of the gamma camera.
After sputum induction, subjects remained in front of the gamma
camera for an additional 1.5 h. Subjects who were not randomized to
receive an induced sputum after their aerosol deposition remained
seated in front of the gamma camera for 2-h after aerosol deposition.
Subjects returned the following day for a 24-h postretention gamma
camera image. At least 48 h later, subjects returned for their second
visit period and received a randomized aerosol deposition with or with-



















) central deposition without induced sputum.
 
Central (Bolus) Airway Deposition Technique
 
An aerosol bolus is a discrete volume of air containing particles sand-
wiched within an inhaled volume of particle-free air. The depth to
which the bolus penetrates into the lung is determined by the volume
of the bolus and the volume of air inhaled after its insertion into the
air stream. An injection at the beginning of an inhalation would pref-
erentially deliver the aerosol to the periphery, whereas inhalation of
the bolus at the end of a breath tends to deliver the aerosol to the ex-
trathoracic and conducting airways. The inhalation is generally fol-
lowed by a period of breath holding to maximize particle deposition
on airway surfaces. In attempting to confine the aerosol to the ADS of




 50 ml) and delivered to shallow
volumetric front depths (VFD), i.e., less than 150 ml (13, 14). The
VFD is an estimate of the penetration of particles into the respiratory
tract and represents the volume inspired from the point when the first
particles enter the mouth to the end of inhalation (14). By normaliz-
ing the VFD to an individual’s ADS, the aerosol bolus may deposit
more similarly in subjects of variable lung size.
On our central (bolus) airway deposition study days, a small bolus





SC (50 mCi) was prepared using TechneScan Sulfur Colloid Kits (Mallinck-










Tc-SC particles in solution are submicronic with a number mean




m and geometric standard deviation of 1.75. The solu-





m mass median aerodynamic diameter (MMAD) polydis-



















By computer-controlled activation of the compressed air source used to
disperse the nebulizer solution, the boluses were delivered to a VFD of
0.6 ADS for each subject. After inhalation of each bolus under con-
trolled conditions (500 ml tidal volume at 125 ml/s flow), the subject held
his or her breath for 5 s followed by a rapid exhalation to maximally de-
posit the particles on the conducting airways. Also during the bolus inha-
lations the relative aerosol concentration and respired volumes were
measured by photometry and a pneumotachograph at the mouth to de-
termine the VFD of each inhaled bolus. In general, inhalation of 20 to 30
boluses over a 15-min period was required to deliver sufficient activity to




Ci), as monitored by a single-crystal NaI
detector placed at the subject’s back.
 
Peripheral Airway Deposition Technique
 
To deliver particles to the peripheral, alveolar region of the lung, we neb-
ulized radiolabeled SC solution with an Ultravent nebulizer (Mallinck-





inhaled this aerosol while matching a 1-L tidal volume, 12 breaths/minute
breathing pattern displayed on an oscilloscope. The combination of this
slow, deep breathing pattern and the small particle size was chosen to
maximize alveolar deposition relative to that in the bronchial airways (17,









 2 min), again as monitored by




To assess the degree of central (C) versus peripheral (P) airway depo-
sition within the lung for all four study days in each subject, we calculated




Tc activity, normalized to the xenon-133 equilibrium
scan, on the initial deposition scan after radiolabeled aerosol inhala-
tion (12, 19). This normalization was done to account for the differ-
ence in relative lung areas and thickness between the central and pe-
Figure 1. Gamma camera image of the whole lung (left and right) 4 min
after a central airway deposition of radiolabeled 99mTc-SC particles for one
subject. Dotted lines indicate the outline of the right and left lung
based on the xenon equilibrium scan. The central airways region of in-
terest (ROI) (solid line) is shown for both lungs (area  25% of the
whole lung ROI). Greater deposited activity is shown in red. The ROI
for the stomach is shown in the bottom quadrant of the left lung to
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ripheral regions. Whereas both the central and peripheral regions
(Figure 1) overlay alveoli and small airways, the central region also in-
corporates large, bronchial airways not present in the peripheral re-
gion. Thus, increases in C/P to values greater than 1.0 reflect in-
creased large airway deposition. To eliminate activity associated with
the stomach in the left P region, it was necessary to exclude the lower
left lung base when creating the left lung region of interest (Figure 1,
lower left region). This should have had no effect on our C/P compar-
isons because the same regions were used for both central and periph-





Xe equilibrium) in each case. A rectangular region bor-





was used to determine, by computer analysis, the whole lung clear-
ance as a percentage of the initial counts (background-corrected and
decay-corrected) over the gamma camera scanning period of 2 h and
at 24 h. Again, care was taken to ensure that the activity in the stom-




Sputum induction and collection
 
. Induced sputum samples were col-
lected and measured for radioactivity at 40 min after aerosol deposi-
tion. We followed the method published by Pin and coworkers (20) with





) and vital capacity (VC) were measured before saline inhala-




 values that matched a
20% fall from baseline were determined and recorded. An ultrasonic
nebulizer was filled with 30 ml of 5% hypertonic saline (NaCl) for the
first of two 12-min inhalations. During each inhalation period, the
subject was encouraged to come off the mouthpiece at any time to
cough if a sputum sample from the lower airways (i.e., not from the
back of the throat) was ready for expectoration. A separate sterile
container designated as waste was used to collect saliva–salt water
that collected in the mouth and throat during the inhalation periods.
After the 12-min inhalation period and before expectoration, subjects




) Gargle and rinse the




) Scrape and clear the back of the throat (to
avoid the inclusion of nonairway fluid samples), and then expectorate




) Blow one’s nose. Next the subjects delivered a
chesty cough and expectorated the secretions into a sterile specimen
jar, which was capped and placed on ice. Each subject coughed as
many times as he or she felt necessary in order for airway secretions to
be expectorated. This was typically 5 to 7 cough attempts. A postin-









 decreased by less than 20% from the baseline value, the sub-
jects repeated the second 12-min inhalation period with 5% saline fol-




Immediately after sputum induction, the expectorated sample and
waste container were weighed and taken to a scintillation counter
(Nuclear Data Sodium Iodide [NaI] Scintillation Counter; Smyrna, GA)
to determine the level of radioactivity (counts) present in each. The spu-
tum sample was transferred to a sterile Petri dish and its characteris-
tics macroscopically (or microscopically if necessary with an inverted
microscope) recorded in terms of color, consistency, and degree of
salivary contamination. The sputum plugs were manually separated
from surrounding saliva with sterile forceps, selected, and transferred
to a preweighed test tube. Radioactivity was measured on the selected
sputum sample and recorded. The radioactive counts associated with
the sputum sample were normalized to the amount of activity depos-
ited in the lung for each day. The sample was then weighed and a vol-




 the sample weight was
added to the sample. Separate experiments determined that DTT had




Tc label to remain affixed to the SC
particles. The sample was gently aspirated with a pipette and agitated
(bench rocked) for 15 min. A volume of Dulbecco’s phosphate-buff-




 the sample weight was then added to
the sample, and the sample was bench rocked for 5 min.





lon mesh and the weight of the cell suspension was recorded. After
this, the sample was centrifuged (1,000 rpm, 5 min) and the superna-
tant collected into a separate tube. A separate experiment also
showed that this level of centrifugation was not capable of spinning
down the “free” SC particles in solution. The level of radioactivity
was measured in the cell pellet and supernatant. Next, a Neubauer
hemocytometer and trypan blue exclusion staining (1:1 dilution of
sample:trypan blue) were used to determine the total cell count (ex-
cluding squamous epithelial cells) and cell viability.
 
Normalization of Sputum Radioactivity to
Deposited Radioactivity
 
The radioactivity measured in the sputum samples by the scintillation
detector was also dependent on the total amount of activity deposited
in the lung for either the central or peripheral depositions. It was
therefore necessary to normalize these sputum counts in order to
make both intrasubject and intersubject comparisons. This normaliza-
tion was accomplished as follows:




The whole lung gamma camera counts were determined from the ini-
tial deposition image (i.e., Figure 1) (before beginning the sputum in-
duction procedure) and the rectangular regions bordering the left and
right lungs. For each subject and study day, the measured counts were




Tc has a 6-h half-




Statistically significant differences between multiple study end points
were assessed using a repeated-measures one-way analysis of variance
Measured counts
whole lung gamma camera counts for(
specific subject and study day )
average whole lung gamma counts for all subjects on both(


















































F 34 160 64 No 2.63 3.55 92 106 150
F 26 173 62 No 3.42 4.19 100 104 150
M 50 190 105 No 5.40 6.73 116 117 270
F 52 157 82 No 2.36 2.67 116 108 130
M 22 191 77 No 4.74 6.15 91 102 170
M 44 196 93 No 4.07 6.08 90 106 180
M 20 173 84 No 3.30 4.07 80 85 170
F 21 168 67 No 3.46 3.87 121 117 130
F 23 163 73 No 3.11 3.42 115 110 160
F 20 168 61 No 3.12 3.64 108 109 130
Average 31.2 173.9 76.8 3.56 4.43 103 106 160








 anatomic dead space.
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 test (two-tailed). Welche’s correction was applied when equal
variances could not be assumed or were found to be significantly dif-








Table 1 shows anthropometric data for all subjects (4 male, 6








 and FVC. Mean





FVC were 103 and 106%, respectively.
Table 2 shows the mean (SEM) total and differential cell
count data from induced sputum samples collected after cen-





 0.05) were observed in total and differential cell
counts between central and peripheral aerosol depositions.
Satisfactory sputum samples were obtained from all subjects
on all occasions (i.e., each selected sputum sample from all
subjects on all occasions contained greater than 1,000 mg of
selected sample).




 SEM number of NRC recov-
ered in the total expectorated sputum sample, the manually
selected portion of the total expectorated sample, and the
nonprocessed waste (saliva generated from the induction pro-
cess) for the central deposition. A minimal number of NRC





reflecting a negligible contribution of counts owing to deposi-
tion in the mouth and oropharynx during the deposition pro-
cedure. In contrast, a high percentage of NRC was recovered





 86%), indicating that the majority of radiolabeled par-
ticles were associated with sputum plugs.
 




 SEM NRC recovered in the to-
tal selected sputum sample, the processed cell pellet, and the





 0.001) in the selected sputum, cell pellet, and super-
natant samples after a central deposition versus a peripheral dep-
osition. The difference in NRC between the total expectorated
sample and the sum of the cell pellet and supernatant was caused
by retained radiolabeled particles on the nylon-mesh filter paper
as a result of the sputum processing procedure.
Figure 4A shows the clearance kinetics of radiolabeled parti-
cles from the whole lung following sputum induction at 40 min,
120 min, and 24 h after central and peripheral aerosol deposition.
Significantly more radiolabeled particles were cleared from the
whole lung at 40 min, 120 min, and 24 h after central versus pe-




 0.0001). Figure 4B shows the C/
P ratio for the central and peripheral airway depositions. A signif-
icantly higher C/P ratio was observed with the central deposition









Figure 5A demonstrates the effect of induced sputum on
clearance kinetics for the central deposition. Initial C/P ratios













 0.39). Compared with the
control condition where no induced sputum was performed, in-




 0.001) the clearance of
radiolabeled particles from the whole lung at both 40 and 120
min after central deposition. There was no observed effect of
sputum induction on clearance at 24 h after deposition. Figure 5B
shows the effect of induced sputum on clearance after a periph-
eral deposition. Again, there was no difference in initial C/P












 0.17). Unlike the central deposition, no
significant differences between sputum and control were ob-




The widespread use and growing popularity of induced spu-
tum as a means of examining airways inflammation in human
volunteers has made it important to confirm experimentally
the location from which the sputum sample derives. Several
studies already suggest that induced sputum selectively sam-
ples the central airways (1–5). These studies performed com-
parative leukocyte analyses on induced sputum, BAL, and
bronchial secretions and showed greater neutrophil propor-
tions in both sputum and bronchial samples compared with
BAL. Although these data provide useful information to sup-
port the premise that sputum is an airways phenomenon, they
do not necessarily test this hypothesis.
In this study, we used a novel radiolabeled aerosol bolus
delivery system that yielded more quantifiable data to show
that induced sputum selectively samples the central airways
with little or no contribution from the peripheral airways. The
success of the bolus technique to deposit relatively more parti-
cles in the central versus peripheral airways was evident in two
 





























































































































 Differential cell counts are % nucleated cells excluding squamous epithelial cells. Mean % squamous epithelial cells were 10.1% (cen-
tral) and 16.5% (peripheral).
Figure 2. Mean (SEM) NRC present in the total expectorated sputum,
selected sputum, and nonprocessed waste after a central airways dep-
osition in healthy individuals (n  10). A minimal amount of radioac-
tivity was present in the waste component (*indicates  5% of the to-
tal) compared with the selected component (**indicates 86% of the
total). Total  total expectorated sputum sample; Selected  manually
selected portion of the sputum sample; Waste  nonprocessed saliva
generated from the induction process; *indicates  5% of the total;
**indicates 86% of the total.
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ways. First, the C/P ratio was greater than 1 and significantly
increased for the central versus peripheral deposition, imply-
ing greater deposition in all the bronchial airways, because
deposition at the level of generations 1 to 3 will not likely oc-
cur independent of enhanced deposition throughout the rest of
the conducting airways (generations 4 to 16). Second, we found
that with the central deposition maneuver, approximately 60% of
the particles cleared by 24 h (with or without sputum induction,
Figure 5A), whereas with the peripheral deposition maneuver we
only had approximately 20% clearance of particles through 24 h.
From our own work (12), it is reasonable to assume that percent-
age of clearance through 24 h is an estimate of particles initially
depositing in the conducting airways. Consequently, this repre-
sents a 3-fold greater particle deposition in conducting airways
for the central versus peripheral maneuver. In addition to suc-
cessfully applying the bolus technique in this study, we also con-
sidered whether any potential biases occurred in the concentra-
tion of deposited aerosol between peripheral and central airways
owing to the possible differences that may be present in airways
surface liquid volume. Based on estimates from the literature of
airways surface liquid volume depth (10 to 30 m) (21) and air-
ways surface area (6,300 cm2) (22), we calculated the airways sur-
face liquid volume to be 6.3 ml compared with a morphologically
estimated alveolar fluid volume of 7.15 ml (23, 24). These limited
data suggest that volumes of airways surface liquid may not differ
that much between airway and alveolar regions. Consequently,
there should be minimal bias associated with variable airways
surface liquid volumes in central and peripheral regions.
When we compared the level of radioactivity recovered in the
selected sputum sample after a central versus peripheral airways
deposition, we observed a marked increase in the number of
NRC recovered in all portions of the selected sample (total, cell
pellet, supernatant) after a central airways deposition. The NRC
in the selected portion represented 86% of the total sample,
whereas its weight was less than 50% of the total. This indicates
that particles were concentrated in the selected portion of the
Figure 3. Mean (SEM) NRC recovered in the total selected sputum
sample, cell pellet, and supernatant fraction immediately after
deposition of radiolabeled aerosol in central versus peripheral air-
ways in healthy individuals (n  10). Significantly more radioactiv-
ity was present in all sample portions after the central deposition
(filled bar) versus peripheral (open bar) deposition (*p  0.001).
*Significantly different from central deposition (p  0.001).
Figure 4. (A) Mean (SEM) whole lung clear-
ance of radiolabeled particles with induced
sputum after central and peripheral airways
deposition in healthy individuals (n  10).
Significantly greater clearance was observed
at 40 min, 120 min, and 24 h for sputum
induction after a central (dark bar) and pe-
ripheral (clear bar) airways deposition (*p 
0.0001). (B) Mean (SEM) C/P ratios for the
central and peripheral airway deposition in
healthy individuals (n  10). Significantly
greater C/P ratios were observed after the
central (filled bar) versus peripheral (open
bar) airways deposition (*p  0.0005).
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sputum sample and not simply due to selecting 86% of the total
sample weight. Furthermore, there were minimal (yet detect-
able) levels of NRC present in the sputum samples after the pe-
ripheral deposition. If induced sputum did in fact sample the pe-
ripheral airways to any significant degree, we clearly would not
have observed as great a magnitude difference in particle recov-
ery between the central and peripheral airway depositions. The
detection of some radioactive counts after the peripheral deposi-
tion reflects the fact that a minimal amount of aerosol was depos-
ited in the bronchial airways during the peripheral deposition
condition. This is supported by the fact that the bulk of radioac-
tive counts from the total sputum samples (either on central or
peripheral study days) were associated with the selected “plug”
sample, and within that, most of the particles were associated
with the supernatant compared with the cells. Because the super-
natant is likely to contain the mucous gel portion of airway secre-
tions, and because mucins primarily derive from glandular and
goblet cell secretions of conducting airways, these data provide
further evidence that the total sputum samples after central and
peripheral deposition are derived from the same conducting air-
ways. Moreover, because we observed a significantly greater C/P
ratio and a greater percent clearance at 24 h for the central versus
peripheral deposition, we were assured that the bolus aerosol
deposition more selectively targeted the central airways relative
to the peripheral airways, and hence established valid central and
peripheral deposition conditions.
The measurement and comparison of clearance kinetics after
a central and peripheral airways deposition also provided good
evidence of selective central airways sampling by induced sputum
(Figure 4A). Previous studies have shown that inhalation of hy-
pertonic saline, or cough alone, can enhance clearance of depos-
ited particles from the lung when compared with clearance with-
out hypertonic saline or clearance without cough. However,
these previous studies (25, 26) did not attempt to distinguish be-
tween centrally (airway) and peripherally (alveolar) deposited
particles when assessing the effects of hypertonic saline or cough.
After sputum induction, we observed 50% clearance at 40 min
for a central deposition, compared with a negligible 5.0% clear-
ance for a peripheral deposition. This is consistent with previous
reports that little or no aerosol is expected to be cleared at 40 min
after a peripheral airway deposition (18, 19). Because induced
sputum employs the combination of both hypertonic saline inha-
lation and cough, it may not have been surprising that we demon-
strated greatly enhanced clearance, especially for our central
deposition pattern, compared with the no sputum control condi-
tion, considering that cough is most effective in the large conduct-
ing airways, where shear rates are highest (greatest air velocities)
and the depth of airway surface fluid is likely greatest (27). Fi-
nally, as further evidence that the sputum induction technique
does not sample the deep lung, the 24-h retention (i.e., 100 	 %
24-h clearance, Figures 5A and 5B) was unchanged for both cen-
tral and peripheral depositions between the sputum and no spu-
tum induction study days. This percentage of particles retained at
24 h is a reflection of those particles depositing deepest (most al-
veolar) in the lung (12, 18, 19). These data further confirm our
hypothesis that induced sputum samples derived from the central
airways, not the alveolar regions of the lung.
For the central deposition sample, the average ratio of ac-
tivity in the cell pellet (i.e., cell-associated particle ratio) versus
the sum of the cell pellet plus supernatant was 12  3%, if we
considered only those individuals for whom we recovered
more than 80% of total sputum activity in the cell pellet plus
supernatant. Similar radiolabeled aerosol studies performed in
animal models (hamster macrophages) show a higher cell-asso-
Figure 5. (A) Effect of induced sputum on mean (SEM)
whole lung clearance of radiolabeled particles after a
central deposition in healthy individuals (n  10). Sig-
nificantly greater clearance was observed at the 40-min
and 120-min time points after a central airways deposi-
tion with induced sputum (filled bar) versus without in-
duced sputum (open bar) (*p  0.0001). (B) Effect of in-
duced sputum on mean (SEM) whole lung clearance of
radiolabeled particles after a peripheral deposition in
healthy subjects (n  10). There was no significant (p 

0.05) difference in clearance with induced sputum ver-
sus without induced sputum at 40 min, 120 min, and
24 h after a peripheral airways deposition.
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ciated particle ratio (32 to 34%) immediately after deposition
(28, 29). Experimentally, preferential filtering of cell-associ-
ated particles during sputum processing in our experiments
may partially explain this difference, but several other reasons
might also explain the greater uptake of particles in the animal
studies. These include species differences, a larger particle size
used in the animal studies (6-m polystyrene particle versus
0.2-m SC particle), as well as a higher delivered dose of parti-
cle to the animals’ airways. A greater particle size and higher
delivered dose of particles to the hamsters’ airways may have
stimulated active recruitment of monocytes and monocyte-like
macrophages to the site of deposition in the airways. Because
newly recruited monocytes and monocyte-like macrophages
are more phagocytic compared with macrophages with a longer
residence time in the airways (1), a large proportion of the
macrophage pool in the hamster airways may have possessed
increased phagocytic capacity. In our study, it was unlikely that
the small particle load delivered in 20 to 30 boluses stimulated
any significant recruitment of young phagocytes into the air-
ways from the peripheral blood. Consequently, a compara-
tively smaller proportion of highly phagocytic macrophages
may have interacted with the deposited particles in our sub-
jects. It is interesting to speculate whether the airway macro-
phages in our subjects required a longer incubation time (be-
fore sputum induction) to optimally interact with the deposited
aerosol to produce a greater cell-associated particle ratio, pos-
sibly approaching the percentages observed in the animal stud-
ies. Time course studies are currently under way in our labora-
tory to investigate this intriguing question.
Conclusions
With the use of a radiolabeled aerosol bolus inhalation tech-
nique, this study directly tested and confirmed the hypothesis
that induced sputum samples derive from the central airways
with little or no contribution from the peripheral airways. In ad-
dition, the combination of hypertonic saline and spontaneous
cough did not enhance clearance of particles from the peripheral
alveolar spaces. Finally, preliminary data suggest minimal inter-
action between airway macrophages and deposited particles im-
mediately after deposition.
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